The clinical spectrum of prostate cancer

Ralph W deVere White, D. F. Paulson, J. F. Glenn

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Review of 206 consecutive patients with prostatic carcinoma and a potential for 10 yr followup indicates the efficacy of vigorous surgical or hormonal management. Satisfactory documented followup was achieved in 88% of the group for 5 yr and 82% of the group for 10 yr. Among 33 patients undergoing radical perineal prostatectomy survival rates were 84% at 5 yr and 58% at 10 yr. In the entire series, irrespective of modality of treatment, approximately half of the patients survived 5 yr and a 4th for 10 yr. Hormonal therapy of choice was orchiectomy combined with relatively high doses of estrogens, with no indication of significant cardiovascular morbidity or mortality. Interestingly, stage A disease (often diffuse, anaplastic and unsuspected) demonstrated a significantly increased mortality risk when compared to stage B (localized and usually well differentiated) carcinoma of the prostate.

Original languageEnglish (US)
Pages (from-to)323-327
Number of pages5
JournalJournal of Urology
Volume117
Issue number3
StatePublished - 1977
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Carcinoma
Orchiectomy
Mortality
Prostatectomy
Prostate
Estrogens
Survival Rate
Morbidity
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

deVere White, R. W., Paulson, D. F., & Glenn, J. F. (1977). The clinical spectrum of prostate cancer. Journal of Urology, 117(3), 323-327.

The clinical spectrum of prostate cancer. / deVere White, Ralph W; Paulson, D. F.; Glenn, J. F.

In: Journal of Urology, Vol. 117, No. 3, 1977, p. 323-327.

Research output: Contribution to journalArticle

deVere White, RW, Paulson, DF & Glenn, JF 1977, 'The clinical spectrum of prostate cancer', Journal of Urology, vol. 117, no. 3, pp. 323-327.
deVere White, Ralph W ; Paulson, D. F. ; Glenn, J. F. / The clinical spectrum of prostate cancer. In: Journal of Urology. 1977 ; Vol. 117, No. 3. pp. 323-327.
@article{897fa375aca2450aaaf0f9eaaa140da6,
title = "The clinical spectrum of prostate cancer",
abstract = "Review of 206 consecutive patients with prostatic carcinoma and a potential for 10 yr followup indicates the efficacy of vigorous surgical or hormonal management. Satisfactory documented followup was achieved in 88{\%} of the group for 5 yr and 82{\%} of the group for 10 yr. Among 33 patients undergoing radical perineal prostatectomy survival rates were 84{\%} at 5 yr and 58{\%} at 10 yr. In the entire series, irrespective of modality of treatment, approximately half of the patients survived 5 yr and a 4th for 10 yr. Hormonal therapy of choice was orchiectomy combined with relatively high doses of estrogens, with no indication of significant cardiovascular morbidity or mortality. Interestingly, stage A disease (often diffuse, anaplastic and unsuspected) demonstrated a significantly increased mortality risk when compared to stage B (localized and usually well differentiated) carcinoma of the prostate.",
author = "{deVere White}, {Ralph W} and Paulson, {D. F.} and Glenn, {J. F.}",
year = "1977",
language = "English (US)",
volume = "117",
pages = "323--327",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - The clinical spectrum of prostate cancer

AU - deVere White, Ralph W

AU - Paulson, D. F.

AU - Glenn, J. F.

PY - 1977

Y1 - 1977

N2 - Review of 206 consecutive patients with prostatic carcinoma and a potential for 10 yr followup indicates the efficacy of vigorous surgical or hormonal management. Satisfactory documented followup was achieved in 88% of the group for 5 yr and 82% of the group for 10 yr. Among 33 patients undergoing radical perineal prostatectomy survival rates were 84% at 5 yr and 58% at 10 yr. In the entire series, irrespective of modality of treatment, approximately half of the patients survived 5 yr and a 4th for 10 yr. Hormonal therapy of choice was orchiectomy combined with relatively high doses of estrogens, with no indication of significant cardiovascular morbidity or mortality. Interestingly, stage A disease (often diffuse, anaplastic and unsuspected) demonstrated a significantly increased mortality risk when compared to stage B (localized and usually well differentiated) carcinoma of the prostate.

AB - Review of 206 consecutive patients with prostatic carcinoma and a potential for 10 yr followup indicates the efficacy of vigorous surgical or hormonal management. Satisfactory documented followup was achieved in 88% of the group for 5 yr and 82% of the group for 10 yr. Among 33 patients undergoing radical perineal prostatectomy survival rates were 84% at 5 yr and 58% at 10 yr. In the entire series, irrespective of modality of treatment, approximately half of the patients survived 5 yr and a 4th for 10 yr. Hormonal therapy of choice was orchiectomy combined with relatively high doses of estrogens, with no indication of significant cardiovascular morbidity or mortality. Interestingly, stage A disease (often diffuse, anaplastic and unsuspected) demonstrated a significantly increased mortality risk when compared to stage B (localized and usually well differentiated) carcinoma of the prostate.

UR - http://www.scopus.com/inward/record.url?scp=0017347783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017347783&partnerID=8YFLogxK

M3 - Article

C2 - 839594

AN - SCOPUS:0017347783

VL - 117

SP - 323

EP - 327

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3

ER -